Deardorf Caren — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Deardorf Caren has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Caren Deardorf appears as a Director of Crinetics Pharmaceuticals, Inc. in SEC filings dated through 2026-06-22. Crinetics is a Nasdaq-listed biotechnology company focused on peptide therapeutics and rare disease programs. The public record available from SEC filings identifies Deardorf as a board director, but detailed biographical information is not widely published. Variants of the name (e.g., Caren Deardorf, Caren Deardorff) may appear in other filings or sources. There is no public indication in the provided context that Deardorf has died as of the most recent filing date.
Role
Director
Notability
40/100
Board memberships
Crinetics Pharmaceuticals, Inc.
Awards & honors
Director, Crinetics Pharmaceuticals, Inc. (as of 2026-06-22)
Caren Deardorf appears as a Director of Crinetics Pharmaceuticals, Inc. in SEC filings dated through 2026-06-22. Crinetics is a Nasdaq-listed biotechnology company focused on peptide therapeutics and rare disease programs. The public record available from SEC filings identifies Deardorf as a board director, but detailed biographical information is not widely published. Variants…
How many SEC Form 4 filings has Deardorf Caren submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Deardorf Caren's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
